title: Targeting ECM Disrupts Cancer Progression.
abstract: Metastatic complications are responsible for more than 90% of cancer-related deaths. The progression from an isolated tumor to disseminated metastatic disease is a multistep process, with each step involving intricate cross talk between the cancer cells and their non-cellular surroundings, the extracellular matrix (ECM). Many ECM proteins are significantly deregulated during the progression of cancer, causing both biochemical and biomechanical changes that together promote the metastatic cascade. In this review, the influence of several ECM proteins on these multiple steps of cancer spread is summarized. In addition, we highlight the promising (pre-)clinical data showing benefits of targeting these ECM macromolecules to prevent cancer progression.
authors.affiliation: Biotech Research and Innovation Centre (BRIC), University of Copenhagen (UCPH) , Copenhagen , Denmark.
authors.forename: Freja A
authors.initials: FA
authors.lastname: Venning
authors.affiliation: Biotech Research and Innovation Centre (BRIC), University of Copenhagen (UCPH) , Copenhagen , Denmark.
authors.forename: Lena
authors.initials: L
authors.lastname: Wullkopf
authors.affiliation: Biotech Research and Innovation Centre (BRIC), University of Copenhagen (UCPH) , Copenhagen , Denmark.
authors.forename: Janine T
authors.initials: JT
authors.lastname: Erler
keywords: collagen I; extracellular matrix; hyaluronan; metastasis; periostin; tenascin C